Between January 1 and June 30, 2020, among the included tissue donors (who were not suspected at the time of having COVID-19 and no vaccine was available), there were 3 confirmed positive donor samples by alternate NAT testing among 26 initial positives that had a confirmatory test result, about 0.12% of donors tested. This evidence concerns the gene BRD2 and COVID-19.